Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Caza

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Kidney International|June 20, 2025
Detection and characterization of NELL1 autoantibodies in NELL1 positive membranous nephropathyTiffany N Caza, Brock A Arivett, Samar I Hassen, et al.
Kidney International|February 1, 2020
Serum amyloid P deposition is a sensitive and specific feature of membranous-like glomerulopathy with masked IgG kappa depositsChristopher P Larsen, Shree G Sharma, Tiffany N Caza, et al.
Kidney International Reports|October 24, 2022
Renal Prognosis of COVID-19 Associated NephropathyGabriel Giannini, Juan Carlos Q Velez, Rebecca M May, et al.
Kidney International|October 12, 2020
Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritisTiffany N Caza, Samar I Hassen, Michael Kuperman, et al.
Kidney360|April 4, 2022
Transforming Growth Factor Beta Receptor 3 (TGFBR3)-Associated Membranous NephropathyTiffany N Caza, Samar I Hassen, Daniel J Kenan, et al.
Kidney International|November 6, 2025
Dual-antigen membranous nephropathySamih H Nasr, Tiffany N Caza, Christopher P Larsen, et al.
Kidney International|August 24, 2020
NELL1 is a target antigen in malignancy-associated membranous nephropathyTiffany N Caza, Samar I Hassen, Zeljko Dvanajscak, et al.
Annals of the Rheumatic Diseases|July 31, 2013
HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLETiffany N Caza, David R Fernandez, Gergely Talaber, et al.
Kidney International Reports|November 29, 2023
Clinical and Histopathologic Characteristics of Pediatric Patients With Primary Membranous NephropathyAnne M Kouri, Tiffany N Caza, Laurence H Beck, et al.
Kidney International|April 29, 2023
Proprotein convertase subtilisin/kexin type 6 (PCSK6) is a likely antigenic target in membranous nephropathy and nonsteroidal anti-inflammatory drug useSanjeev Sethi, Marta Casal Moura, Benjamin Madden, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Kidney International|June 20, 2025
Detection and characterization of NELL1 autoantibodies in NELL1 positive membranous nephropathyTiffany N Caza, Brock A Arivett, Samar I Hassen, et al.
Kidney International|February 1, 2020
Serum amyloid P deposition is a sensitive and specific feature of membranous-like glomerulopathy with masked IgG kappa depositsChristopher P Larsen, Shree G Sharma, Tiffany N Caza, et al.
Kidney International Reports|October 24, 2022
Renal Prognosis of COVID-19 Associated NephropathyGabriel Giannini, Juan Carlos Q Velez, Rebecca M May, et al.
Kidney International|October 12, 2020
Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritisTiffany N Caza, Samar I Hassen, Michael Kuperman, et al.
Kidney360|April 4, 2022
Transforming Growth Factor Beta Receptor 3 (TGFBR3)-Associated Membranous NephropathyTiffany N Caza, Samar I Hassen, Daniel J Kenan, et al.
Kidney International|November 6, 2025
Dual-antigen membranous nephropathySamih H Nasr, Tiffany N Caza, Christopher P Larsen, et al.
Kidney International|August 24, 2020
NELL1 is a target antigen in malignancy-associated membranous nephropathyTiffany N Caza, Samar I Hassen, Zeljko Dvanajscak, et al.
Annals of the Rheumatic Diseases|July 31, 2013
HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLETiffany N Caza, David R Fernandez, Gergely Talaber, et al.
Kidney International Reports|November 29, 2023
Clinical and Histopathologic Characteristics of Pediatric Patients With Primary Membranous NephropathyAnne M Kouri, Tiffany N Caza, Laurence H Beck, et al.
Kidney International|April 29, 2023
Proprotein convertase subtilisin/kexin type 6 (PCSK6) is a likely antigenic target in membranous nephropathy and nonsteroidal anti-inflammatory drug useSanjeev Sethi, Marta Casal Moura, Benjamin Madden, et al.
Pageof 5